Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Accured Revenue - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Climb Bio (CLYM) Preferred Shares Issued (2020 - 2021)

Climb Bio filings provide 2 years of Preferred Shares Issued readings, the most recent being $93.9 million for Q2 2021.

Quarterly Preferred Shares Issued changed N/A to $93.9 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $93.9 million through Mar 2022, changed N/A year-over-year, with the annual reading at $93.9 million for FY2021, 1807.39% up from the prior year.
Preferred Shares Issued hit $93.9 million in Q2 2021 for Climb Bio, up from $34000.0 in the prior quarter.
Across five years, Preferred Shares Issued topped out at $93.9 million in Q2 2021 and bottomed at $34000.0 in Q1 2021.